Sodium cromoglycate and the corticosteroids attenuate intrinsic airway reactivity in asthmatics Newsletter Article 19 February 2013 Pages: 3 - 3
The ideal antihypertensive - how close is captopril? Newsletter Article 19 February 2013 Pages: 4 - 4
Fenoldopam: administration controls BP in hypertensive crises Newsletter Article 19 February 2013 Pages: 4 - 5
OM 8980: is as effective as auranofin and better tolerated in rheumatoid arthritis Newsletter Article 19 February 2013 Pages: 5 - 5
Nisoldipine: has chronic antihypertensive activity that is maintained at rest and during exercise Newsletter Article 19 February 2013 Pages: 5 - 5
A general practice intervention programme lowers the rate of analgesic prescribing Newsletter Article 19 February 2013 Pages: 6 - 6
Diltiazem Does Not Improve Mortality and Reinfarction Rates Newsletter Article 19 February 2013 Pages: 6 - 6
Digoxin Remains the Drug of Choice for Atrial Fibrillation Management Newsletter Article 19 February 2013 Pages: 7 - 7
Is There a Place for IV Salbutamol in Severe Acute Asthma? Newsletter Article 19 February 2013 Pages: 7 - 8
Alternatives to Intravenous Nitroglycerin in Unstable Angina Newsletter Article 19 February 2013 Pages: 8 - 9
Progesterone Eliminates Severe Premenstrual Exacerbations of Asthma Newsletter Article 19 February 2013 Pages: 9 - 9
Buccal and Oral Prochlorperazine have Equivalent Antiemetic Efficacy Newsletter Article 19 February 2013 Pages: 12 - 12
Amiodarone has Similar Anti-ischaemic Efficacy to Atenolol Newsletter Article 19 February 2013 Pages: 13 - 13
Surgical and Medical Treatments Produce Similar Survival Rates… Newsletter Article 19 February 2013 Pages: 14 - 14
Simvastatin Lowers Cholesterol Levels Throughout a 24-Week Study Newsletter Article 19 February 2013 Pages: 14 - 14
Regression of Cardiac Hypertrophy with Antihypertensive Therapy Newsletter Article 19 February 2013 Pages: 15 - 15
Diltiazem's Haemorheological Effects May Have Clinical Advantages Newsletter Article 19 February 2013 Pages: 17 - 17
Refractory myeloma: an ongoing oncological challenge Newsletter Article 19 February 2013 Pages: 17 - 18
Octreotide: A world first launch for Sandoz's somatostatin analogue in NZ Newsletter Article 19 February 2013 Pages: 19 - 20